Risk Evaluation and Mitigation Strategy (REMS): FDA Perspective on What Physicians Need to Know
2015
For some drugs, risk mitigation measures beyond FDA-approved labeling are deemed necessary. Learn more about these Risk Evaluation and Mitigation Strategies (REMS).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI